The value of Silva pattern system in early cervical adenocarcinoma

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000035755

Enrollment

Unknown

Registered

2020-08-16

Start date

2020-09-01

Completion date

Unknown

Last updated

2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical adenocarcinoma

Interventions

Experimental group:Silva pattern system

Control group:NCCN

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: (1) Pathological results: common type of cervical adenocarcinoma, stage IA1-IIA2; (2) Informed consent and signed informed consent form; (3) Those who have the condition of follow-up and are willing to continue follow-up in our hospital.

Exclusion criteria

Exclusion criteria: (1) Other pathological types were stage I-II cervical cancer and stage III-IV cervical cancer; (2) Combined with severe internal and external diseases; (3) Those who cannot complete the follow-up.

Design outcomes

Primary

Measure	Time frame
3-year overall survival rate;	—

Countries

China

Contacts

Public ContactKeqin Hua

Obstetrics and Gynecology Hospital of Fudan University

huakeqin@126.com+86 15921515900

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026